Skip to main content
N4 PHARMA PLC logo

N4 PHARMA PLC — Investor Relations & Filings

Ticker · N4P ISIN · GB00BYW8QM32 LEI · 213800I841D2RKMFK955 IL Professional, scientific and technical activities
Open in API
Filings indexed 840 across all filing types
Latest filing 2020-12-31 Declaration of Voting R…
Country GB United Kingdom
Listing IL N4P

About N4 PHARMA PLC

https://n4pharma.com/

N4 Pharma PLC is a specialist pharmaceutical company focused on the development of Nuvec®, its proprietary silica nanoparticle delivery system. This platform technology is designed to enhance the cellular delivery and potency of nucleic acid-based treatments, such as vaccines and cancer therapies. The company's primary focus is on applying Nuvec® to enable advanced therapies for oncology and infectious diseases. N4 Pharma's business model involves developing and out-licensing its technology to pharmaceutical and biotechnology partners to improve the performance of new and existing drugs.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a short announcement identified by the 'RNS Number' header, indicating it is a regulatory filing from the London Stock Exchange's news service. The content explicitly states the 'Total Voting Rights' as of a specific date (31 December 2020) and provides the total number of ordinary shares (181,080,349). This information is crucial for shareholders to calculate their notification requirements under the FCA's Disclosure Guidance and Transparency Rules. This type of mandatory disclosure regarding the total share capital and voting rights does not fit neatly into the specific categories like ER, IR, or CAP. Since it is a formal regulatory announcement provided via RNS, and it is not a report itself (it's a short notification), it best fits the general 'Regulatory Filings' category (RNS) or potentially a specific capital/share announcement. However, given the context of providing the denominator for voting rights notification, it is a standard regulatory disclosure. Since there is no specific code for 'Total Voting Rights', RNS is the most appropriate fallback for a general regulatory update distributed via the RNS system.
2020-12-31 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1934 characters) and contains the header 'RNS Number : 7254J'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a general regulatory announcement disseminated via the RNS system, rather than a specific financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or MANG), the most appropriate classification is the general regulatory filing fallback.
2020-12-23 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1917 characters) and contains specific identifiers like 'RNS Number : 7244J' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content discusses a 'Price Monitoring Extension' and an 'auction call period' extension, which is a routine market operational announcement rather than a comprehensive financial report (like 10-K or IR) or a specific corporate action (like DIV or CAP). Since it is a general regulatory announcement disseminated via the RNS system and does not fit into the more specific categories (like DIRS, DIV, ER, etc.), the most appropriate classification is the general Regulatory Filings category.
2020-12-23 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and is issued via 'RNS Number : 3969I' on '14 December 2020'. This form is used to report changes in significant share ownership, specifically detailing the percentage of voting rights held by an individual (NIGEL JAMES THEOBALD) crossing a notification threshold. This directly corresponds to the definition of 'Major Shareholding Notification' (MRQ). Although it is an RNS filing, MRQ is the more specific category for this type of regulatory disclosure.
2020-12-14 English
Half-year Report
Interim / Quarterly Report Classification · 1% confidence The document is a 'Half year Report' for Evgen Pharma plc for the period ended 30 September 2020. It contains detailed operational highlights, financial highlights, a Chairman's and Chief Executive's statement, and a financial review including specific loss and cash flow figures. This meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. H1 2020
2020-12-10 English
Placing to raise £2 million
Share Issue/Capital Change Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a 'Placing to raise £2 million' through the issuance of new ordinary shares, which is a capital-raising activity. This type of announcement, especially when originating from RNS, is typically classified as a general regulatory announcement or a specific filing related to capital changes. Since it is a direct announcement of a financing event (Placing) and is distributed via RNS, it fits best under the 'Capital/Financing Update' (CAP) category, as it details fundraising. However, given the context of RNS distribution and the nature of the announcement (a specific corporate action update), it also strongly aligns with the general 'Regulatory Filings' (RNS) category, which serves as a fallback for specific corporate actions not covered by other primary codes like 10-K or ER. Since 'CAP' is a specific category for fundraising, it is the most precise fit for the content describing the £2 million placing. The document is not a short announcement pointing to a separate report, but the report itself detailing the transaction.
2020-12-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.